This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: October 14, 2022
Source: https://www.ipsen.com/press-releases/ipsen-to-acquire-epizyme-expanding-its-portfolio-in-oncology/
Reason: Acquired by Ipsen
Last recorded trade on: October 14, 2022
Source: https://www.ipsen.com/press-releases/ipsen-to-acquire-epizyme-expanding-its-portfolio-in-oncology/
Epizyme
EPZM
₹126.64
Share price
0.00%
Change (1 day)
-64.36%
Change (1 year)
Categories
Earnings for Epizyme (EPZM)
Earnings in 2022 (TTM): -₹15.85 Billion
According to Epizyme's latest financial reports the company's current earnings are ₹53 Million. In 2021 the company made an earning of -₹19.56 Billion a decrease over its 2020 earnings that were of -₹19.43 Billion.
Earnings history for Epizyme from 2012 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -₹15.85 Billion | -18.97% |
| 2021 | -₹19.56 Billion | 0.63% |
| 2020 | -₹19.43 Billion | 32.62% |
| 2019 | -₹14.65 Billion | 32.74% |
| 2018 | -₹11.04 Billion | -6.38% |
| 2017 | -₹11.79 Billion | 22.37% |
| 2016 | -₹9.64 Billion | -15.63% |
| 2015 | -₹11.42 Billion | 140.78% |
| 2014 | -₹4.75 Billion | 1660.47% |
| 2013 | -₹0.27 Billion | 307.16% |
| 2012 | -₹66.17 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -₹68.11 Billion | 330.61% | 🇺🇸 USA |
 | ₹1.175 T | -7,529.44% | 🇨🇭 Switzerland |
 | ₹378.59 B | -2,493.62% | 🇬🇧 UK |
 | ₹604.17 B | -3,919.84% | 🇺🇸 USA |